Abiopharma

News list

📋 MIKKELSEN JAN MOLLER (Officer) plans to sell 87K shares of Ascendis Pharma A/S (at $211.99 each, total $18.4M) Filed: Jan 13, 2026 | ID: 000011

Full text

News bot Jan. 13, 2026, 7:03 p.m.
📋 Form 144 Filing: MIKKELSEN JAN MOLLER

Company: Ascendis Pharma A/S

Filing Date: 2026-01-13

Relationship: Officer; PRESIDENT CEO
Planned Sale Details:
- Security: AMERICAN DEPOSITORY SHARES
- Shares to be Sold: 86,860
- Price per Share: $211.99
- Total Value: $18,413,630.85
- Planned Sale Date: 2026-01-13
- Broker: CITIGROUP GLOBAL MARKETS
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36815
- Issuer Contact Phone: 45 70 22 22 44
- Issuer Address: TUBORG BOULEVARD 12, HELLERUP, G7, DK2900
- Broker Address: 390 GREENWICH ST, NEW YORK, NY, 10013
- Shares Outstanding: 61695211.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: CONFORMED SIGNATURE ON FILE